Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 26, 2023; 11(33): 7972-7979
Published online Nov 26, 2023. doi: 10.12998/wjcc.v11.i33.7972
Published online Nov 26, 2023. doi: 10.12998/wjcc.v11.i33.7972
Table 3 Occurrence of adverse events, n (%)
| Factors | Control group (n = 52) | Observation group (n = 56) | χ2 | P value |
| Rash | 2 (3.85) | 1 (1.79) | - | - |
| Gastrointestinal discomfort | 2 (3.85) | 1 (1.79) | - | - |
| Dyslipidemia | 4 (7.69) | 2 (3.57) | - | - |
| Osteoporosis | 3 (5.77) | 0 (0.00) | - | - |
| Total | 11 (21.15) | 4 (7.14) | 4.426 | 0.035 |
- Citation: Sun YF, Liu LL, Jiang SS, Zhang XJ, Liu FJ, Zhang WM. Influence of ganglioside combined with methylprednisolone sodium succinate on efficacy and neurological function in patients with acute myelitis. World J Clin Cases 2023; 11(33): 7972-7979
- URL: https://www.wjgnet.com/2307-8960/full/v11/i33/7972.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i33.7972